Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0023 | 0.0375 | 1 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD7 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.013 | 0.0206 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.2422 | 0.2422 |
Echinococcus granulosus | muscleblind protein | 0.029 | 1 | 1 |
Echinococcus multilocularis | EGFP:Bcl2 fusion protein | 0.008 | 0.2422 | 0.2422 |
Echinococcus granulosus | Bcl 2 ous antagonist:killer | 0.008 | 0.2422 | 0.2422 |
Plasmodium vivax | enoyl-acyl carrier protein reductase | 0.0188 | 0.6329 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.0023 | 0.0375 | 0.0375 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0023 | 0.0375 | 0.0593 |
Schistosoma mansoni | apoptosis regulator bax | 0.008 | 0.2422 | 1 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0023 | 0.0375 | 1 |
Plasmodium falciparum | enoyl-acyl carrier reductase | 0.0188 | 0.6329 | 1 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0023 | 0.0375 | 0.0593 |
Echinococcus granulosus | EGFP:Bcl2 fusion protein | 0.008 | 0.2422 | 0.2422 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0023 | 0.0375 | 0.0593 |
Brugia malayi | Apoptosis regulator proteins, Bcl-2 family protein | 0.008 | 0.2422 | 0.2422 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0017 | 0.0164 | 0.026 |
Loa Loa (eye worm) | apoptosis regulator protein | 0.008 | 0.2422 | 0.2422 |
Schistosoma mansoni | bcl-2 homologous antagonist/killer (bak) | 0.008 | 0.2422 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0164 | 0.0164 |
Mycobacterium leprae | NADH-DEPENDENT ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE INHA (NADH-DEPENDENT ENOYL-ACP REDUCTASE) | 0.0188 | 0.6329 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.0023 | 0.0375 | 0.0375 |
Trypanosoma brucei | oxidoreductase-like protein | 0.0013 | 0 | 0.5 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0017 | 0.0164 | 0.026 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0375 | 0.0593 |
Echinococcus multilocularis | Bcl 2 ous antagonist:killer | 0.008 | 0.2422 | 0.2422 |
Loa Loa (eye worm) | hypothetical protein | 0.029 | 1 | 1 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD3 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.013 | 0.0206 |
Chlamydia trachomatis | enoyl-acyl-carrier protein reductase | 0.0188 | 0.6329 | 1 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0017 | 0.0164 | 0.026 |
Trypanosoma cruzi | beta-ketoacyl-ACP reductase | 0.0013 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0164 | 0.0164 |
Brugia malayi | AMP-binding enzyme family protein | 0.0023 | 0.0375 | 0.0375 |
Trypanosoma brucei | beta-ketoacyl-ACP reductase | 0.0013 | 0 | 0.5 |
Mycobacterium ulcerans | enoyl-(acyl carrier protein) reductase | 0.0188 | 0.6329 | 1 |
Trypanosoma cruzi | beta-ketoacyl-ACP reductase | 0.0013 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0023 | 0.0375 | 0.0593 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0375 | 0.0593 |
Mycobacterium tuberculosis | NADH-dependent enoyl-[acyl-carrier-protein] reductase InhA (NADH-dependent enoyl-ACP reductase) | 0.0188 | 0.6329 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0375 | 0.0375 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0023 | 0.0375 | 0.0593 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD35 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.013 | 0.0206 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0017 | 0.0164 | 0.026 |
Loa Loa (eye worm) | hypothetical protein | 0.029 | 1 | 1 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0023 | 0.0375 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0164 | 0.0164 |
Mycobacterium ulcerans | hypothetical protein | 0.0023 | 0.0375 | 0.0593 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0023 | 0.0375 | 0.0593 |
Echinococcus multilocularis | muscleblind protein | 0.029 | 1 | 1 |
Trichomonas vaginalis | hypothetical protein | 0.0188 | 0.6329 | 0.5 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0023 | 0.0375 | 0.0593 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0375 | 0.0593 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0017 | 0.0164 | 0.026 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0023 | 0.0375 | 1 |
Schistosoma mansoni | hypothetical protein | 0.008 | 0.2422 | 1 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0023 | 0.0375 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0375 | 0.0375 |
Echinococcus multilocularis | muscleblind protein 1 | 0.029 | 1 | 1 |
Trypanosoma cruzi | oxidoreductase-like protein, putative | 0.0013 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.008 | 0.2422 | 1 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0023 | 0.0375 | 0.0593 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0375 | 0.0375 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0164 | 0.0164 |
Wolbachia endosymbiont of Brugia malayi | enoyl-ACP reductase | 0.0188 | 0.6329 | 1 |
Schistosoma mansoni | hypothetical protein | 0.008 | 0.2422 | 1 |
Toxoplasma gondii | enoyl-acyl carrier reductase ENR | 0.0188 | 0.6329 | 1 |
Onchocerca volvulus | 0.0023 | 0.0375 | 1 | |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0023 | 0.0375 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0164 | 0.0164 |
Trypanosoma brucei | pteridine reductase 1 | 0.0013 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD5 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.013 | 0.0206 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.